Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,513
Total Claims
$521K
Drug Cost
500
Beneficiaries
$1,043
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+47%
Opioid rate vs peers
67.6% vs 45.9% avg
+116%
Cost per patient vs peers
$1,043 vs $483 avg
+150%
Brand preference vs peers
10.3% vs 4.1% avg
Opioid Prescribing
67.6%
Opioid Rate
5,752
Opioid Claims
$315K
Opioid Cost
21.1%
Long-Acting Rate
This provider's opioid prescribing rate of 67.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 878 claims · $337K
Generic: 7,635 claims · $184K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 167 | $67K |
| Buprenorphine Hcl | 91 | $62K |
| Methylnaltrexone Bromide | 17 | $43K |
| Hydrocodone/Acetaminophen | 1,516 | $39K |
| Naloxegol Oxalate | 90 | $38K |
| Oxycodone Hcl | 1,742 | $36K |
| Oxycodone Hcl/Acetaminophen | 591 | $20K |
| Buprenorphine | 55 | $17K |
| Ubrogepant | 17 | $16K |
| Oxycodone Hcl | 30 | $15K |
| Galcanezumab-Gnlm | 19 | $14K |
| Lemborexant | 38 | $13K |
| Rimegepant Sulfate | 11 | $13K |
| Linaclotide | 22 | $12K |
| Morphine Sulfate | 585 | $12K |
Prescribing Profile
50
Unique Drugs
12.0
Anomaly Score
Patient Profile
63
Avg Age
62%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data